Screener
Aptevo Therapeutics APVO Q2 2026 earnings
Reported August 14, 2026 · Before market open
EPS-$5.31Beat by $0.71
EPS estimate-$6.02
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$3.72
Versus estimates
Diluted EPS
FAQ
- When did Aptevo Therapeutics report Q2 2026 earnings?
- Aptevo Therapeutics (APVO) reported Q2 2026 earnings on August 14, 2026 before market open.
- What were Aptevo Therapeutics's Q2 2026 revenue and EPS?
- Aptevo Therapeutics reported eps of $-5.31 for Q2 2026.
- Did Aptevo Therapeutics beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-6.02 by $0.71.
- How did Aptevo Therapeutics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 96.5% from $-151.08.
- Where can I find Aptevo Therapeutics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-349380) and the 10-Q periodic report (0001193125-26-350559) directly on SEC EDGAR. The filing index links above go to sec.gov.
